Table 4.

Association between PCSK9 E670G polymorphism and lipid levels

		TC (mmol/l)	TG (mmol/l)	HDL-C (mmol/l)	LDL-C (mmol/l)	Apo A1 (g/l)	Apo B (g/l)	AIP
CAD	AA	4.59 ± 1.06	1.85 ± 1.53	1.08 ± 0.27	2.93 ± 0.93	1.18 ± 0.23	0.97 ± 0.30	0.15 ± 0.28
	AG + GG	4.64 ± 0.94	1.77 ± 1.15	1.07 ± 0.22	3.01 ± 0.78	1.19 ± 0.21	0.99 ± 0.26	0.05 ± 0.24
	P	0.565	0.876	0.798	0.462	0.574	0.457	0.339
Controls	AA	4.41 ± 0.97	1.77 ± 1.51	1.16 ± 0.30	2.64 ± 0.80	1.23 ± 0.24	0.91 ± 0.26	0.09 ± 0.34
	AG + GG	4.46 ± 0.90	1.63 ± 1.02	1.17 ± 0.34	2.67 ± 0.74	1.23 ± 0.24	0.90 ± 0.27	0.08 ± 0.36
	P	0.831	0.482	0.823	0.822	0.929	0.912	0.937

CAD coronary artery disease, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, AIP atherogenic index of plasma